Cargando…

The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease

The relationship between interleukin-6 and C-reactive protein was evaluated in patients with benign (n=59) and malignant (n=86) prostate disease. The correlation coefficients for patients with benign prostatic disease and prostate cancer were r(s)=0.632, P<0.001 and r(s)=0.663, P<0.001, respec...

Descripción completa

Detalles Bibliográficos
Autores principales: McArdle, P A, McMillan, D C, Sattar, N, Wallace, A M, Underwood, M A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410056/
https://www.ncbi.nlm.nih.gov/pubmed/15505624
http://dx.doi.org/10.1038/sj.bjc.6602211
_version_ 1782155923610927104
author McArdle, P A
McMillan, D C
Sattar, N
Wallace, A M
Underwood, M A
author_facet McArdle, P A
McMillan, D C
Sattar, N
Wallace, A M
Underwood, M A
author_sort McArdle, P A
collection PubMed
description The relationship between interleukin-6 and C-reactive protein was evaluated in patients with benign (n=59) and malignant (n=86) prostate disease. The correlation coefficients for patients with benign prostatic disease and prostate cancer were r(s)=0.632, P<0.001 and r(s)=0.663, P<0.001, respectively. These results indicate that the relationship between interleukin-6 and C-reactive protein is similar in patients with benign and malignant prostate disease.
format Text
id pubmed-2410056
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24100562009-09-10 The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease McArdle, P A McMillan, D C Sattar, N Wallace, A M Underwood, M A Br J Cancer Short Communication The relationship between interleukin-6 and C-reactive protein was evaluated in patients with benign (n=59) and malignant (n=86) prostate disease. The correlation coefficients for patients with benign prostatic disease and prostate cancer were r(s)=0.632, P<0.001 and r(s)=0.663, P<0.001, respectively. These results indicate that the relationship between interleukin-6 and C-reactive protein is similar in patients with benign and malignant prostate disease. Nature Publishing Group 2004-11-15 2004-10-26 /pmc/articles/PMC2410056/ /pubmed/15505624 http://dx.doi.org/10.1038/sj.bjc.6602211 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Short Communication
McArdle, P A
McMillan, D C
Sattar, N
Wallace, A M
Underwood, M A
The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease
title The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease
title_full The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease
title_fullStr The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease
title_full_unstemmed The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease
title_short The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease
title_sort relationship between interleukin-6 and c-reactive protein in patients with benign and malignant prostate disease
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410056/
https://www.ncbi.nlm.nih.gov/pubmed/15505624
http://dx.doi.org/10.1038/sj.bjc.6602211
work_keys_str_mv AT mcardlepa therelationshipbetweeninterleukin6andcreactiveproteininpatientswithbenignandmalignantprostatedisease
AT mcmillandc therelationshipbetweeninterleukin6andcreactiveproteininpatientswithbenignandmalignantprostatedisease
AT sattarn therelationshipbetweeninterleukin6andcreactiveproteininpatientswithbenignandmalignantprostatedisease
AT wallaceam therelationshipbetweeninterleukin6andcreactiveproteininpatientswithbenignandmalignantprostatedisease
AT underwoodma therelationshipbetweeninterleukin6andcreactiveproteininpatientswithbenignandmalignantprostatedisease
AT mcardlepa relationshipbetweeninterleukin6andcreactiveproteininpatientswithbenignandmalignantprostatedisease
AT mcmillandc relationshipbetweeninterleukin6andcreactiveproteininpatientswithbenignandmalignantprostatedisease
AT sattarn relationshipbetweeninterleukin6andcreactiveproteininpatientswithbenignandmalignantprostatedisease
AT wallaceam relationshipbetweeninterleukin6andcreactiveproteininpatientswithbenignandmalignantprostatedisease
AT underwoodma relationshipbetweeninterleukin6andcreactiveproteininpatientswithbenignandmalignantprostatedisease